354-Medulloblastoma Stem Cell Programs and Progression
This research explores the molecular origins and progression of medulloblastoma, a highly aggressive pediatric brain cancer. While sequencing has defined four major molecular subgroups, current treatments fail to eliminate the stem and progenitor cells that drive tumor growth and drug resistance. The authors argue for the development of faithful human models, such as 3D organoids, to better mirror human-specific brain development compared to traditional mouse models. A significant focus is placed on the post-transcriptional landscape, suggesting that mechanisms like alternative splicing offer…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.